首页> 外国专利> METHOD FOR TREATMENT OF CEREBRAL VASOSPASM IN ANEURYSMAL SUBARACHNOID HEMORRHAGE

METHOD FOR TREATMENT OF CEREBRAL VASOSPASM IN ANEURYSMAL SUBARACHNOID HEMORRHAGE

机译:动脉瘤蛛网膜下腔出血中脑血管痉挛治疗方法

摘要

FIELD: medicine. ;SUBSTANCE: invention relates to medicine, namely to neurosurgery, vascular surgery, neurology, and can be used for X-ray endovascular chemo-angioplasty for the treatment of cerebral vasospasm in aneurysmal subarachnoid hemorrhage. A microcatheter is inserted into the cerebral arteries, through which 10 or 20 mg of Nimotop diluted in 500 or 1000 ml of 0.9% NaCl solution, respectively, from a dark glass container, is superselectively injected into the cerebral pool, through a standard system for intravenous infusions, at a rate of one drop per second using high-pressure cuffs coupled with a diagnostic catheter. With a decrease in blood pressure, the introduction of vasopressors is indicated, with the ineffectiveness of which and an uncontrolled decrease in blood pressure, the infusion rate of the drug Nimotop must be reduced, and the systolic blood pressure level should be maintained within 130-150 mm Hg. The decision to complete X-ray endovascular chemo-angioplasty is taken with a decrease in the linear blood flow rate of less than 200 cm/s without signs of increasing cerebral vasospasm during control cerebral angiography. With cerebral vasospasm in the right and/or left carotid basin, a diagnostic catheter is inserted into the middle third of one of the internal carotid arteries. With the development of vasospasm with stenosis of the lumen of one or more cerebral arteries to more than 70%, 2 vials of Nimotop solution (20 mg) are injected, diluted each in 500 ml of 0.9% NaCl. If vasospasm with cerebral artery stenosis is less than 70%, 1 vial is injected. Thus, either 10 mg or 20 mg of Nimotop is administered for 15-20 minutes by drop infusion. Next, the catheter is reinstalled into the contralateral internal carotid artery and the patient is transferred to the intensive care unit, where the final dose of the drug Nimotop is administered with constant monitoring of evaluation criteria: blood pressure, heart rate, linear blood flow rates. The maximum dose of the administered Nimotop for 1 session does not exceed 20 mg. When detecting cerebral spasm in the vertebrobasilar system, X-ray endovascular chemo-angioplasty is performed in the vertebrobasilar system according to the proposed scheme through a diagnostic catheter installed in the middle third of the dominant vertebral artery, through which, with the development of vasospasm with stenosis of the lumen of one or more cerebral arteries to more than 70%, 2 vials of Nimotop solution (20 mg), diluted each in 500 ml 0.9% NaCl are selectively injected. If vasospasm with cerebral artery stenosis is less than 70%, 1 vial is injected. Thus, either 10 mg or 20 mg of Nimotop is administered with constant monitoring of evaluation criteria: blood pressure, heart rate, linear blood flow rates. The maximum dose of the administered Nimotop for 1 session does not exceed 20 mg. ;EFFECT: method provides the possibility of reducing surgical injury while maintaining a high degree of effectiveness in the treatment of cerebral vasospasm with aneurysmal subarachnoid hemorrhage due to the proposed method of X-ray endovascular chemo-angioplasty. ;1 cl, 12 dwg, 2 ex
机译:领域:医学。 ;物质:发明涉及医学,即神经外科,血管手术,神经病学,可用于X射线血管内化学血管成形术,用于治疗动脉瘤蛛网膜瘤出血中的脑血管痉挛。将微直升插入脑动脉中,通过其中从暗玻璃容器中分别在500或1000ml 0.9%NaCl溶液中稀释的10或20mg Nimotop,通过标准系统超出暗玻璃容器。静脉注射输注,每秒使用高压箍与诊断导管的高压袖口的速率。随着血压的降低,指出了血管加压素的引入,其无效性和血压的不受控制的降低,必须降低药物Nimotop的输注速率,并且收缩压水平应保持在130- 150 mm Hg。完成X射线血管内血管内血管成形术的决定,随着对照脑血管造影期间的增加而没有增加脑血管痉挛的迹象。在右侧和/或左颈盆腔中具有脑血管痉挛,将诊断导管插入其中一个内部颈动脉的中间三分之一。随着血管痉挛的发展,具有一个或多个脑动脉的内腔狭窄,将20%的脑动脉延长,注射2个小瓶的Nimotop溶液(20mg),稀释500ml 0.9%NaCl。如果具有脑动脉狭窄的血管痉挛小于70%,则注射1个小瓶。因此,通过滴输注给药10mg或20mg Nimotop 15-20分钟。接下来,将导管重新安装到对侧内部颈动脉中,患者转移到重症监护室,其中药物Nimotop的最终剂量持续监测评价标准:血压,心率,线性血流率。 1个会议的施用Nimotop的最大剂量不超过20mg。当检测椎弓鼠系统中的脑痉挛时,通过安装在主导椎动脉的中间三分之一的诊断导管,通过该方案在椎骨血管内的系统中进行X射线血管内化学血管成形术通过血管痉挛的发展对于一个或多个脑动脉的狭窄,一个或多个脑动脉的腔体超过70%,2个小瓶的Nimotop溶液(20mg),选择性地注入500ml 0.9%NaCl中的各自稀释。如果具有脑动脉狭窄的血管痉挛小于70%,则注射1个小瓶。因此,施用10mg或20mg Nimotop的持续监测评价标准:血压,心率,线性血流率。 1个会议的施用Nimotop的最大剂量不超过20mg。 ;效果:方法提供减少手术损伤的可能性,同时保持高度有效性,在治疗具有动脉瘤性蛛网膜下腔出血的脑血管痉挛时,由于X射线血管内化学成形术的方法。 ; 1 cl,12 dwg,2前

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号